ArticlebioRxiv : the preprint server for biology2025
Small amphiphilic DNA for programmable transmembrane signaling and amplification.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Transmembrane proteins such as G-protein coupled receptors (GPCRs) transmit molecular signals across lipid bilayers through stimulus-responsive allosteric mechanisms, where extracellular ligand binding induces G-protein dissociation to initiate downstream signaling. Mimicking such specific signal transduction pathway with DNA nanostructures has remained challenging due to the incompatibility between hydrophilic DNA and hydrophobic membranes, and the difficulty of engineering allosteric DNA reactions across lipid bilayers. Here, we overcome these limitations by exploiting DNA Hybridization Across Lipid for Optical Signaling (HALOS) using an amphiphilic DNA hairpin comprising toehold for recognition, stem for stability, loop, and cholesterols for transmembrane anchoring. Upon binding of a single-stranded nucleic acid target stimuli, strand invasion through the toehold initiates conformational switching in HALOS, enabling signal transduction across membrane. Experimentally, we demonstrate that DNA hybridization across lipid membrane can occur, contradicting the prevailing view that DNA hybridization cannot proceed through hydrophobic barriers. All-atom molecular dynamics (MD) simulations reveal that cholesterol tags stabilize the DNA stem within the bilayer, preserving the hairpin structure necessary for transmembrane signaling. By combining the HALOS with a non-enzymatic isothermal hybridization chain reaction (HCR), we establish a platform that enables intracellular nucleic acid target detection and amplified fluorescent reporting from outside synthetic vesicles and live mammalian cells achieving nanomolar sensitivity. HALOS expands the toolkit for membrane-integrated DNA nanotechnology and opens avenues for lysis-free diagnostics, synthetic cell and biology, and targeted therapeutic activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.